- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/16 - Radicals substituted by nitrogen atoms
Patent holdings for IPC class C07D 233/16
Total number of patents in this class: 51
10-year publication summary
|
5
|
5
|
4
|
5
|
5
|
2
|
2
|
2
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Pharma AG | 1061 |
4 |
| Ingevity South Carolina, LLC | 242 |
4 |
| GPCP IP Holdings LLC | 1639 |
4 |
| The Regents of the University of California | 19868 |
2 |
| ExxonMobil Research And Engineering Company | 2582 |
2 |
| ACADIA Pharmaceuticals Inc. | 206 |
2 |
| Friedrich-Alexander-Universitaet Erlangen-Nuernberg | 110 |
2 |
| The Lubrizol Corporation | 1283 |
2 |
| The University of North Carolina at Chapel Hill | 2029 |
2 |
| Hoffmann-La Roche Inc. | 3405 |
1 |
| AstraZeneca AB | 2917 |
1 |
| Massachusetts Institute of Technology | 10036 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6402 |
1 |
| Dow Global Technologies LLC | 10373 |
1 |
| JPMorgan Chase Bank, National Association | 8556 |
1 |
| Purdue Research Foundation | 3583 |
1 |
| Acuitas Therapeutics Inc. | 114 |
1 |
| Argusina, Inc. | 2 |
1 |
| The Board of Trustees of the University of Alabama | 408 |
1 |
| Ceca S.A. | 46 |
1 |
| Other owners | 16 |